PrecisionLife, Sano Genetics partner on studying long COVID
PrecisionLife is joining forces with Sano Genetics to better understand the long-term effects of the coronavirus (long COVID). PrecisionLife’s proprietary combinatorial analytics platform will identify risk factors and potential drug targets by analyzing Sano Genetics’ data from 3,000 U.K. adults suffering from long COVID symptoms. Read More
How has the COVID-19 pandemic affected pediatric care?
What impact has the COVID-19 pandemic had on the care of pediatric cancer patients internationally? It depends on the country, according to Dr. Muhammed Elhadi of the University of Tripoli in Libya. Elhadi spoke with ScienceBoard.net at the recent American Association for Cancer Research meeting in New Orleans. Read More
CoVac-1 vaccine shows promise for immunocompromised patients
At the recent American Association for Cancer Research meeting in New Orleans, ScienceBoard.net spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 vaccine has shown in immunocompromised patients. Read More
COVID-19 protects unvaccinated from reinfection
Unvaccinated people who have a previous COVID-19 infection have a level of protection from future infections that's comparable to protection provided by mRNA vaccines, according to a new study published on April 20 in JAMA Network Open. Read More
Moderna Charitable Foundation awards $5M in initial grants
Biotechnology company Moderna has announced the launch of the Moderna Charitable Foundation. Approximately $5 million in initial grants have been awarded to local and global nonprofits that support groups and causes disproportionately affected by COVD-19. Read More
FDA lifts clinical hold on Immunome's SARS-CoV-2 antibody cocktail
Biopharmaceutical company Immunome said that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its antibody cocktail for the treatment of SARS-CoV-2. Read More
NanoHarmonics acquires Avagen Pharma
Biodiagnostic device company NanoHarmonics has acquired Avagen Pharma, a global distributor of a product that utilizes an advanced drug delivery system to treat premature ejaculation. Read More
Twist launches synthetic RNA capsules
Twist Bioscience has launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in proprietary stainless steel minicapsules provided by Imagene SA. Read More
COVID data repository helps track pandemic in SF hospitals
ORLANDO -- Consistent persistence in the face of chaos is how San Francisco Department of Public Health Chief Information Officer Eric Raffin and his team implemented their COVID-19 hospitalization data repository. Raffin shared his experience during a Tuesday session at the 2022 Healthcare Information and Management Systems Society meeting. Read More
Experience sharing is critical for women in science
Sharing experiences with future generations is key to moving science and biotechnology forward. As a female leader of a biotechnology company, Dr. Bridget Martell, CEO of Artizan Biosciences, shares her experiences and perspectives with ScienceBoard. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter